Literature DB >> 4091999

Aminophylline and mucociliary clearance in patients with irreversible airflow limitation.

M G Pearson, D Ahmad, M J Chamberlain, W K Morgan, S Vinitski.   

Abstract

Were aminophylline to improve mucociliary function, it might prove useful in the management of irreversible airflow limitation. Eight subjects with irreversible airflow limitation due to emphysema inhaled an aerosol of 99mTc sulphur-colloid particles on each of 2 days. On day 1 aminophylline was administered intravenously, while on the other nothing was given. Particle clearance was measured by recording posterior gamma-camera images sequentially over a 24 h period. No significant differences were recorded between aminophylline and control studies, but there were marked variations in clearance between study days and between individuals. These differences were compatible with the known effects of airways obstruction and breathing pattern on the sites of particle deposition within the bronchial tree. The latter factors appeared to exert a far greater influence on the observed mucociliary clearance than did aminophylline.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4091999      PMCID: PMC1400823          DOI: 10.1111/j.1365-2125.1985.tb05130.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

Review 1.  Deposition and clearance of inhaled particles.

Authors:  D Pavia; J R Bateman; S W Clarke
Journal:  Bull Eur Physiopathol Respir       Date:  1980 May-Jun

2.  The effect of oral aminophylline on lung mucociliary clearance in man.

Authors:  P P Sutton; D Pavia; J R Bateman; S W Clarke
Journal:  Chest       Date:  1981-12       Impact factor: 9.410

3.  Aerosol inhalation and depth of deposition in the human lung. The effect of airway obstruction and tidal volume inhaled.

Authors:  D Pavia; M Thomson; H S Shannon
Journal:  Arch Environ Health       Date:  1977 May-Jun

4.  Factors influencing the regional deposition of inhaled particles in man.

Authors:  M J Chamberlain; W K Morgan; S Vinitski
Journal:  Clin Sci (Lond)       Date:  1983-01       Impact factor: 6.124

5.  Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.

Authors:  M R Alexander; W L Dull; J E Kasik
Journal:  JAMA       Date:  1980-11-21       Impact factor: 56.272

  5 in total
  1 in total

Review 1.  Management of chronic airway obstruction: theophylline--is it still necessary?

Authors:  D Ukena; G W Sybrecht
Journal:  Lung       Date:  1990       Impact factor: 2.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.